⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Pablo CasaresM.D

Internal Medicine · El Paso, TX 79912

NPI: 1073827762

Share:

21

🟡 Moderate

Risk Flags

High antipsychotic prescribing (65+)Opioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

14,496

Total Claims

$2.4M

Drug Cost

1,090

Beneficiaries

$2,182

Cost/Patient

Risk Score Breakdown 21/100

Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
Opioid + benzodiazepine combo+8

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

-67%

Opioid rate vs peers

0.7% vs 2.2% avg

+55%

Cost per patient vs peers

$2,182 vs $1,411 avg

+35%

Brand preference vs peers

14.4% vs 10.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

0.7%

Opioid Rate

106

Opioid Claims

$980

Opioid Cost

Long-Acting Rate

Brand vs Generic

86% generic

Brand: 2,053 claims · $2.0M

Generic: 12,211 claims · $331K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Dapagliflozin Propanediol157$245K
Sitagliptin Phosphate155$224K
Empagliflozin135$221K
Dulaglutide64$146K
Mirabegron87$112K
Insulin Glargine,hum.Rec.Anlog101$85K
Apixaban81$80K
Insulin Detemir53$67K
Sucroferric Oxyhydroxide20$67K
Linagliptin43$64K
Semaglutide29$55K
Insulin Lispro36$41K
Insulin Degludec49$33K
Insulin Glargine,hum.Rec.Anlog46$32K
Sacubitril/Valsartan18$28K

Prescribing Profile

169

Unique Drugs

$846K

IRA Negotiated Drugs

$201K

GLP-1 Drugs

21.0

Anomaly Score

Patient Profile

73

Avg Age

60%

Female

2.23

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data